Total Payments
$3,108
2024 Payments
$575.69
Companies
20
Transactions
149
Medicare Patients
1,022
Medicare Billing
$159,174
Payment Breakdown by Category
Food & Beverage$2,823 (90.8%)
Travel$284.72 (9.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,823 | 148 | 90.8% |
| Travel and Lodging | $284.72 | 1 | 9.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $601.97 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $331.79 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $303.23 | 19 | $0 (2024) |
| PFIZER INC. | $293.38 | 16 | $0 (2024) |
| Stryker Corporation | $284.72 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $249.99 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $211.20 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $208.55 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $170.67 | 7 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $88.65 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $575.69 | 27 | ABBVIE INC. ($148.06) |
| 2023 | $1,123 | 43 | Stryker Corporation ($284.72) |
| 2022 | $948.28 | 52 | ABBVIE INC. ($237.86) |
| 2021 | $460.78 | 27 | Novartis Pharmaceuticals Corporation ($87.46) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/17/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: DIABETES | ||||||
| 02/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 520 | 890 | $300,233 | $79,569 |
| 2022 | 8 | 379 | 698 | $195,921 | $60,534 |
| 2021 | 4 | 123 | 231 | $56,195 | $19,070 |
Total Patients
1,022
Total Services
1,819
Medicare Billing
$159,174
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 403 | $114,049 | $35,667 | 31.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 154 | 165 | $56,925 | $14,020 | 24.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 102 | 103 | $57,886 | $13,147 | 22.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 90 | 180 | $36,000 | $10,706 | 29.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 39 | $35,373 | $6,030 | 17.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 117 | 388 | $93,354 | $30,316 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 72 | $35,314 | $10,474 | 29.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 80 | 81 | $21,683 | $6,502 | 30.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 28 | $16,864 | $4,568 | 27.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 68 | $11,614 | $3,717 | 32.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $9,285 | $2,534 | 27.3% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 12 | 17 | $4,046 | $1,316 | 32.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 23 | 23 | $3,761 | $1,108 | 29.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 123 | $29,028 | $9,873 | 34.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 24 | $11,016 | $3,734 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 55 | $9,075 | $3,072 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 28 | 29 | $7,076 | $2,390 | 33.8% |
About Dr. John Heller, MD
Dr. John Heller, MD is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1992292064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Heller, MD has received a total of $3,108 in payments from pharmaceutical and medical device companies, with $575.69 received in 2024. These payments were reported across 149 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,823).
As a Medicare-enrolled provider, Heller has provided services to 1,022 Medicare beneficiaries, totaling 1,819 services with total Medicare billing of $159,174. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Huntersville, NC
- Active Since 04/15/2018
- Last Updated 10/25/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992292064
Products in Payments
- XARELTO (Drug) $331.79
- DALVANCE (Drug) $327.01
- N/A (Device) $284.72
- TEFLARO (Drug) $274.96
- ENTRESTO (Drug) $247.50
- ELIQUIS (Drug) $243.05
- JARDIANCE (Drug) $190.71
- LOKELMA (Drug) $188.20
- LifeVest (Device) $170.67
- DIFICID (Drug) $164.72
- VYNDAQEL (Drug) $89.65
- NUZYRA (Drug) $88.65
- FARXIGA (Drug) $61.79
- LEQVIO (Drug) $55.73
- INJECTAFER (Drug) $52.03
- XIFAXAN (Drug) $43.75
- Ultomiris (Drug) $33.37
- Barostim Neo System (Device) $29.72
- Ozempic (Drug) $27.41
- KEYTRUDA (Biological) $20.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Alexis Smith, D.o, D.O
Internal Medicine — Payments: $492,236
Internal Medicine $492,236
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
Internal Medicine $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Internal Medicine $33,144
Dr. William Mitchell, Md, MD
Internal Medicine — Payments: $31,201
Internal Medicine $31,201
Poras Patel
Internal Medicine — Payments: $20,257
Internal Medicine $20,257
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309
Internal Medicine $17,309